FOLH1 and posterior cortical atrophy: This review highlights the significant impact of approved PSMA-PET imaging agents [68Ga]Ga-PSMA-11 (Locametz®/Illuccix®/GozellixTM), [18F]DCFPyL (Pylarify®/Pylclari®), [18F]PSMA-1007 (Radelumin®), and [18F]rhPSMA-7.3 (Posluma®) on the landscape of PCa detection and management.